- Cytodyn Inc Company Update Call TranscriptDec 14, 2023
- Cytodyn Inc Annual Shareholders Meeting TranscriptNov 09, 2023
- Cytodyn Inc Investment Community Webcast TranscriptJul 24, 2023
- Cytodyn Inc To Provide a Company Update TranscriptApr 11, 2023
- Cytodyn Inc Investment Community Webcast TranscriptDec 29, 2022
- Cytodyn Inc To Host R&D Update-Virtual TranscriptDec 07, 2022
- Cytodyn Inc Investment Community Webcast TranscriptOct 31, 2022
- Cytodyn Inc Investment Community Webcast TranscriptSep 28, 2022
- Cytodyn Inc Investment Community Webcast TranscriptMar 31, 2022
- Cytodyn Inc Investment Community Webcast TranscriptMar 08, 2021
- Cytodyn Inc with Dr.Pourhassan gives an update on CytoDyn's COVID-19 path and more on Proactive TranscriptOct 24, 2020
- Cytodyn Inc Investor Call TranscriptSep 02, 2020
- Cytodyn Inc To Host Investment Community Conference Call TranscriptAug 12, 2020
- Cytodyn Inc Dr. Nader Pourhassan, CytoDyn's CEO, Addresses The False Claims Made By STAT News TranscriptJul 31, 2020
- Cytodyn Inc Special Meeting TranscriptJul 29, 2020
- Cytodyn Inc InvestTalk TranscriptJul 24, 2020
- Cytodyn Inc Dr. Pourhassan Discusses Citron Research's False Report TranscriptJul 02, 2020
- Cytodyn Inc Developing New Therapies for Treatment of Human Immunodeficiency Virus TranscriptJun 18, 2020
- Cytodyn Inc To Host Investment Community Conference Call TranscriptJun 13, 2020
- Cytodyn Inc To Host Investor Community Conference Call TranscriptJun 11, 2020
- Cytodyn Inc Discussion on Company's Trials and COVID19 on Crush the Street Call TranscriptJun 07, 2020
- Cytodyn Inc at CytoDyn (OTC: CYDY) June 2 2020 - Livestream TranscriptJun 02, 2020
- Cytodyn Inc Investor Community Conference Call TranscriptMay 26, 2020
- Cytodyn Inc CytoDyn on Wall Street Reporter with Drs. Pourhassan, Lalezari, and Patterson TranscriptMay 21, 2020
- Cytodyn Inc at Lee Kelso discusses Leronlimab on WOWO radio TranscriptMay 20, 2020
- Cytodyn Inc Shares Manuscript Of Potential Coronavirus Treatment TranscriptMay 07, 2020
- Cytodyn Inc Leronlimab For COVID-19 Coronavirus Treatment TranscriptMay 02, 2020
- Cytodyn Inc Wall Street Reporter TranscriptMay 01, 2020
- Cytodyn Inc At This Drug is Now a Leading Contender to Treat COVID-19 TranscriptApr 27, 2020
- Cytodyn Inc COVID-19 Coronavirus Treatment Clinical Data Update TranscriptApr 18, 2020
- Cytodyn Inc Plans on Moving Forward With COVID-19 Trial TranscriptApr 13, 2020
- Cytodyn Inc at CytoDyn (OTC: CYDY) Coronaovirus Treatment gets FDA EMERGENCY IND + update on HIV & Cancer pipeline TranscriptMar 02, 2020
- Cytodyn Inc at This Week on RedChip TV: 3 Stocks Positioned for Upside in 2020 TranscriptFeb 19, 2020
- Cytodyn Inc at Cytodyn Inc Next Super Stock Live Hosted by Wall Street Reporter TranscriptFeb 11, 2020
- Cytodyn Inc Discusses New HIV Drug and Plans for Commercialization, Addressing $2 Billion Market Call TranscriptFeb 10, 2020
- Cytodyn Inc at Cytodyn Inc Next Super Stock Live Hosted by Wall Street Reporter TranscriptJan 23, 2020
Cytodyn Inc Discussion on Company's Trials and COVID19 on Crush the Street Call Transcript
Hello, everyone, and welcome in to CrushTheStreet.com. I'm Kenneth Ameduri, and I got a really interesting interview today.
We've really covered what has been going on with the virus, the lockdowns, especially as it pertains to the economy, the shutdowns of the restaurants, the businesses. But we're really going to approach it from a scientific angle today and speak to an expert who's tackling this from the remediation side, the medicinal side. And we're really going to understand what is going on with COVID, how serious it is, and what the doctors are doing to deal with maybe future waves, mutations, and whatnot. And I want to get that information from our next guest today.
We are going to be speaking with Dr. Nader Pourhassan, CEO of CytoDyn. The company's ticker symbol is CYDY, and this is a company set to submit a trial design to the FDA to compare the effectiveness of leronlimab versus Gilead's resdesivir (sic - "remdesivir"). So this will be a really interesting conversation today. Dr. Pourhassan, thank you for joining me.
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)